title: [Camptocormia in patients with Parkinson's disease].
abstract: Parkinson's disease (PD) is the most frequent among a broad spectrum of neurologic etiologies of саmptocormia. Camptocormia (CC) is characterized by an abnormal posture with involuntary forward flexion of the trunk, which appears in erect position, increases during prolonged standing or walking, and abates in supine position. CC leads to malposition, increasing postural instability and risk of falling. Treatment of CC in PD includes adjustment of antiparkinsonian medication, injections of botulinum toxin and orthopedical interventions. In this study, CC occurred in sitting position in 62.9% patients and in vertical position in 30% patients, however it disappeared in all patients in a dorsal position. CC was observed throughout the day in 77.1% patients. In 78.6% of PD patients with CC, the pose changed and encouraged with the various factors including weariness and stress; 37.1% patients used a walking stick; 5.7% used a walking aid. CC was accompanied with the painful syndrome in the majority of patients (88.6%). Moreover, 66% of patients had a history of vertebrogenic disorders. The association between CC and the start of dopaminergic treatment was found in 25.7% of patients.
authors.forename: O A
authors.initials: OA
authors.lastname: Orekhova
authors.forename: N V
authors.initials: NV
authors.lastname: Fedorova
authors.forename: A A
authors.initials: AA
authors.lastname: Gamaleia
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D001905:Botulinum Toxins / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D009134:Muscular Atrophy, Spinal / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy / Q000503:physiopathology; D011187:Posture; D011379:Prognosis; D011788:Quality of Life; D013121:Spinal Curvatures / Q000188:drug therapy / Q000209:etiology* / Q000503:physiopathology; D016138:Walking / Q000502:physiology*
chemical_list: D018726:Anti-Dyskinesia Agents; D000978:Antiparkinson Agents; D001905:Botulinum Toxins